CS logo
small CS logo
Iowa Diabetes and Endocrinology Research Center

West Des Moines, Iowa, United States
Diabetes center in West Des Moines, Iowa
1031 Office Park Rd Suite #2, West Des Moines, IA 50265

About Iowa Diabetes and Endocrinology Research Center


"Iowa Diabetes Research's mission is to improve the health and lives of Iowans affected by diabetes. We achieve this by advancing research on diabetes treatment options and by educating patients on how to better manage their diabetes."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
18
Medtronic Diabetes
4
Boehringer Ingelheim
3
DexCom, Inc.
3
Gan and Lee Pharmaceuticals, USA
3
Madrigal Pharmaceuticals, Inc.
2
Novartis
2
Abbott Diabetes Care
1
Calibra Medical, Inc.
1
Jaeb Center for Health Research
1
Jiangsu HengRui Medicine Co., Ltd.
1
Total Rows: 15

Clinical Trials at Iowa Diabetes and Endocrinology Research Center


During the past decade, Iowa Diabetes and Endocrinology Research Center conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 15 clinical trials were completed, i.e. on average, 39.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 12 clinical trials were completed. i.e. 60% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22006655558844880000002211002288Started TrialsCompleted Trails201520162017201820192020202120220246810
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
2008-01-01
2010-10-01
Completed
148
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)
2008-09-01
2011-04-01
Completed
75
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
2011-12-01
2013-06-01
Completed
247
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes
2014-09-01
2016-11-01
Completed
316
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
2015-06-30
2017-10-23
Completed
730
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients
2015-08-01
2017-08-31
Completed
278
Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home
2017-05-25
2024-01-01
Recruiting
280

Rows per page:

1–43 of 43

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Iowa Diabetes and Endocrinology Research Center" #1 sponsor was "Eli Lilly and Company" with 18 trials, followed by "Medtronic Diabetes" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "DexCom, Inc." with 3 trials sponsored and "Gan and Lee Pharmaceuticals, USA" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Iowa Diabetes and Endocrinology Research Center" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Jaeb Center for Health Research" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Mylan GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 18Eli Lilly and Company: 18Medtronic Diabetes: 4Medtronic Diabetes: 4Boehringer Ingelheim: 3Boehringer Ingelheim: 3DexCom, Inc.: 3DexCom, Inc.: 3Gan and LeePharmaceuticals, USA:3Gan and LeePharmaceuticals, USA:3MadrigalPharmaceuticals, Inc.: 2MadrigalPharmaceuticals, Inc.: 2Novartis: 2Novartis: 2Abbott Diabetes Care: 1Abbott Diabetes Care: 1Calibra Medical, Inc.: 1Calibra Medical, Inc.: 1Jaeb Center for HealthResearch: 1Jaeb Center for HealthResearch: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 3Eli Lilly and Company: 3Jaeb Center for HealthResearch: 3Jaeb Center for HealthResearch: 3Juvenile DiabetesResearch Foundation: 2Juvenile DiabetesResearch Foundation: 2Medpace, Inc.: 1Medpace, Inc.: 1Mylan GmbH: 1Mylan GmbH: 1The Leona M. and HarryB. Helmsley CharitableTrust: 1The Leona M. and HarryB. Helmsley CharitableTrust: 1

Clinical Trials Conditions at Iowa Diabetes and Endocrinology Research Center


According to Clinical.Site data, the most researched conditions in "Iowa Diabetes and Endocrinology Research Center" are "Type 2 Diabetes" (9 trials), "Diabetes Mellitus, Type 2" (7 trials), "Diabetes Mellitus, Type 1" (5 trials), "Type 1 Diabetes" (5 trials) and "Type 1 Diabetes Mellitus" (4 trials). Many other conditions were trialed in "Iowa Diabetes and Endocrinology Research Center" in a lesser frequency.

Clinical Trials Intervention Types at Iowa Diabetes and Endocrinology Research Center


Most popular intervention types in "Iowa Diabetes and Endocrinology Research Center" are "Drug" (29 trials), "Device" (11 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Tirzepatide" (9 trials), "Insulin Degludec" (8 trials), "Dulaglutide" (3 trials) and "Insulin Efsitora Alfa" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Iowa Diabetes and Endocrinology Research Center


The vast majority of trials in "Iowa Diabetes and Endocrinology Research Center" are 43 trials for "All" genders.

Clinical Trials Status at Iowa Diabetes and Endocrinology Research Center


Currently, there are NaN active trials in "Iowa Diabetes and Endocrinology Research Center". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Iowa Diabetes and Endocrinology Research Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Iowa Diabetes and Endocrinology Research Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 21Phase 3: 21Phase 2: 9Phase 2: 9Not Applicable: 8Not Applicable: 8Phase 4: 3Phase 4: 3Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 27Completed: 27Active, not recruiting: 8Active, not recruiting: 8Recruiting: 7Recruiting: 7Withdrawn: 1Withdrawn: 1